New Telegraph

COVID-19 vaccine acceptance rises – Research

Against the backdrop of unverified claims linking the administration of COVID-19 vaccines and their booster doses to early deaths all over the world resulting in the rejection of the life-saving medications mostly in African settings, a new study has showing that the acceptance of the vaccine has increased globally.

The results of the study which was led by the Barcelona Institute for Global Health (ISGlobal), Spain and the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) in the United States, have been published in ‘Nature Medicine’. The acceptance of COVID-19 vaccines increased globally, from 75.2 per cent in 2021 to 79.1 per cent in 2022, according to a survey in 23 countries that represent more than 60 per cent of the world’s population. The study underlines a wide variability among countries and the need for tailored communication strategies in addressing vaccine hesitancy.

However, vaccine acceptance decreased in eight countries and almost one in eight vaccinated respondents, particularly younger men and women, were hesitant about receiving a booster dose, the study said. To obtain these data, an international collaboration led by Lazarus and Ayman El-Mohandes, Dean of CUNY SPH, performed a series of surveys starting in 2020 across 23 highly populated countries that were hit hard by the pandemic.

The data reported here correspond to the third survey conducted between June and July 2022, the study said. The countries surveyed were Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Turkey, the United Kingdom and the United States, the study said. Of the 23,000 respondents surveyed, 1000 per country, 79.1 per cent were willing to accept vaccination. This finding represented an increase of 5.2 per cent from June 2021, the study said.

The willingness of parents to vaccinate their children also rose slightly, from 67.6 per cent in 2021 to 69.5 per cent in 2022. However, eight countries observed increased hesitancy from 1.0 per cent in the UK to 21.1 per cent in South Africa, the study said. Almost one in eight, 12.1 per cent, vaccinated respondents were hesitant about booster doses.

This hesitancy was higher among the younger age groups (18-29 years), the study said. Senior author of the study Ayman El-Mohandes said, ‘’We must remain vigilant in tracking these data, containing COVID-19 variants and addressing hesitancy, which may challenge future routine COVID-19 immunisation programmes.’’ The survey also provides new information on COVID-19 treatments received. Globally, ivermectin was taken with the same frequency as other approved medications, even though the WHO and other agencies do not recommend its use to prevent or treat COVID-19, the study said. Almost 40 per cent of respondents reported paying less attention to new COVID-19 information than before and having less support for vaccine mandates, the study said.

Please follow and like us:

Read Previous

Antibiotic use may increase risk of inflammatory bowel disease

Read Next

Concern as Nigeria loses 189 to Lassa fever

Leave a Reply

Your email address will not be published. Required fields are marked *